99 Results

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Riely
    Riely
  4. Giralt
    Giralt
  5. Abou-Alfa
    Abou-Alfa
  6. Ginsberg
    Ginsberg
  7. Kris
    Kris
  8. Postow
    Postow
  9. Shah
    Shah
  10. Tallman
    Tallman

Groups

  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (53)
  3. Hematologic Malignancies, Division of (32)
  4. Center for Hematologic Malignancies (25)
  5. Survivorship Research (20)
  6. Radiology, Department of (17)
  7. Epidemiology and Biostatistics (16)
  8. Thoracic Oncology (16)
  9. GSK Faculty (15)
  10. Biostatistics Service (13)
  1. "hypertransaminasemia"
Formats
  1. Journal Article (87)
  2. Review (10)
  3. Guidelines (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (53)
  3. Hematologic Malignancies, Division of (32)
  4. Center for Hematologic Malignancies (25)
  5. Survivorship Research (20)
  6. Radiology, Department of (17)

More Groups

People
  1. Martin Tallman (7)
  2. Alexander Drilon (6)
  3. Gregory Riely (6)
  4. Robert Motzer (6)
  5. Sergio Giralt (5)
  6. Ghassan Abou-Alfa (4)

More People

Years
  1. 2025 (9)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (4)
  6. 2020 (12)

More Years

Publications
  1. Lancet Oncology (5)
  2. Leukemia and Lymphoma (5)
  3. New England Journal of Medicine (4)
  4. Annals of Oncology (3)
  5. Annals of Surgical Oncology (3)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Springer (10)
  3. Nature Publishing Group (9)
  4. Taylor & Francis Group (9)
  5. Elsevier Science, Inc. (7)
  6. Oxford University Press (6)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy
    Journal Article

    Carlo, M. I.; Attalla, K.; Mazaheri, Y.; Gupta, S.; Yildirim, O.; Murray, S. J.; Coskey, D. T.; Kotecha, R.; Lee, C. H.; Feldman, D. R.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant systemic therapy (NAST) in patients with melanoma: Surgical considerations by the International Neoadjuvant Melanoma Consortium (INMC)
    Guidelines

    van Akkooi, A. C. J.; Hieken, T. J.; Burton, E. M.; Ariyan, C.; Ascierto, P. A.; Asero, S. V. M. A.; Blank, C. U.; Block, M. S.; Boland, G. M.; Caraco, C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Timing of primary tumor resection in synchronous metastatic colon cancer patients undergoing hepatic arterial infusion pump placement
    Journal Article

    Verheij, F. S.; Soares, K. C.; Beets, G. L.; Kok, N. F. M.; Yuval, J. B.; Kemeny, N. E.; Kingham, T. P.; Jarnagin, W. R.; D’Angelica, M. I.; Garcia-Aguilar, J.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): A multicenter, two-cohort, non-randomized phase II trial
    Journal Article

    Pascual, T.; Oliveira, M.; Villagrasa, P.; Ortega, V.; Paré, L.; Bermejo, B.; Morales, S.; Amillano, K.; López, R.; Galván, P.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma: New targets and novel therapies
    Review

    Cheson, B. D.; Nowakowski, G.; Salles, G.
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
    Journal Article

    Laccetti, A. L.; Garmezy, B.; Xiao, L.; Economides, M.; Venkatesan, A.; Gao, J.; Jonasch, E.; Corn, P.; Zurita-Saavedra, A.; Brown, L. C.; more...
    Cancer Medicine (2021)

    Fulltext@MSK | Save
  • A multicenter randomized three-arm phase II study of (1) everolimus, (2) estrogen deprivation therapy (EDT) with leuprolide + letrozole, and (3) everolimus + EDT in patients with unresectable fibrolamellar carcinoma
    Journal Article

    El Dika, I.; Mayer, R. J.; Venook, A. P.; Capanu, M.; LaQuaglia, M. P.; Kobos, R.; O'Neill, A. F.; Chou, J. F.; Ly, M.; Ang, C.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • A single-center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplantation
    Journal Article

    Stern, A.; Su, Y.; Lee, Y. J.; Seo, S.; Shaffer, B.; Tamari, R.; Gyurkocza, B.; Barker, J.; Bogler, Y.; Giralt, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
    Journal Article

    Goldberg, A. D.; Atallah, E.; Rizzieri, D.; Walter, R. B.; Chung, K. Y.; Spira, A.; Stock, W.; Tallman, M. S.; Cruz, H. G.; Boni, J.; more...
    Leukemia Research (2020)

    Fulltext@MSK | Save